InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Explore the full record of transactions filed by Cummings Keith Lamont, Chief Financial Officer. Director active across 1 companies, notably Pliant Therapeutics, INC.. Aggregated, 4 disclosures have been recorded. Total volume traded: €53k. The latest transaction was filed on 20 January 2026 — Cession. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations4 total
US$26,39624,002 shares@ US$1.09970.035% mcap43.0% of flow
Common Stock
SEC:0001746473-26-000012·
€26,39624,002 shares@ €1.09970.035% mcap21.5% of flow
Common Stock
SEC:0001746473-26-000012:0·
€35,02720,000 shares@ €1.75140.047% mcap57.0% of flow
Common Stock
SEC:0001209191-21-054876·
€35,02720,000 shares@ €1.75140.047% mcap28.5% of flow
Common Stock
SEC:0001209191-21-054876:0·
4 of 4 declarations
About Cummings Keith Lamont
Keith Lamont Cummings is the Chief Financial Officer at Pliant Therapeutics, Inc. He oversees the financial operations of the company, ensuring compliance and efficiency in financial processes. His expertise is essential for Pliant's financial management.
